UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Monument Capital Management

Monument Capital Management decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 27.7% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,106 shares of the healthcare conglomerate’s stock after selling 807 shares during the period. Monument Capital Management’s holdings in UnitedHealth Group were worth $1,042,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Tealwood Asset Management Inc. increased its position in UnitedHealth Group by 0.4% during the 4th quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after purchasing an additional 19 shares during the period. Atlas Private Wealth Advisors grew its holdings in shares of UnitedHealth Group by 1.1% in the 4th quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock worth $923,000 after acquiring an additional 19 shares during the period. Prentice Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 0.8% in the 4th quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after acquiring an additional 19 shares during the period. Baker Avenue Asset Management LP grew its holdings in shares of UnitedHealth Group by 1.7% in the 3rd quarter. Baker Avenue Asset Management LP now owns 1,219 shares of the healthcare conglomerate’s stock worth $615,000 after acquiring an additional 20 shares during the period. Finally, Granite Harbor Advisors Inc. grew its holdings in shares of UnitedHealth Group by 2.9% in the 3rd quarter. Granite Harbor Advisors Inc. now owns 718 shares of the healthcare conglomerate’s stock worth $362,000 after acquiring an additional 20 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on UNH shares. JPMorgan Chase & Co. upped their price target on UnitedHealth Group from $546.00 to $559.00 and gave the stock an “overweight” rating in a report on Thursday, May 30th. TD Cowen lowered their target price on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a report on Wednesday, April 10th. Piper Sandler increased their target price on UnitedHealth Group from $566.00 to $571.00 and gave the company an “overweight” rating in a report on Wednesday, April 17th. Morgan Stanley lowered their target price on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a report on Friday, April 5th. Finally, HSBC upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 target price on the stock in a report on Wednesday, June 5th. Three equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Trading Down 1.7 %

Shares of UNH traded down $8.48 during trading hours on Wednesday, hitting $489.76. The stock had a trading volume of 1,072,208 shares, compared to its average volume of 4,267,989. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market cap of $450.77 billion, a P/E ratio of 30.01, a P/E/G ratio of 1.48 and a beta of 0.60. The company’s fifty day simple moving average is $498.64 and its 200 day simple moving average is $501.12. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period last year, the company posted $6.26 EPS. The business’s quarterly revenue was up 8.6% on a year-over-year basis. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a $2.10 dividend. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. This represents a $8.40 annualized dividend and a yield of 1.72%. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s dividend payout ratio is currently 51.34%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.